These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27751686)

  • 1. Correlation of PSMA-Targeted
    Tosoian JJ; Gorin MA; Rowe SP; Andreas D; Szabo Z; Pienta KJ; Pomper MG; Lotan TL; Ross AE
    Clin Genitourin Cancer; 2017 Feb; 15(1):e65-e68. PubMed ID: 27751686
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted
    Werner RA; Sheikhbahaei S; Jones KM; Javadi MS; Solnes LB; Ross AE; Allaf ME; Pienta KJ; Lapa C; Buck AK; Higuchi T; Pomper MG; Gorin MA; Rowe SP
    Ann Nucl Med; 2017 Nov; 31(9):696-702. PubMed ID: 28831739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Comparison of PET Imaging with PSMA-Targeted
    Rowe SP; Li X; Trock BJ; Werner RA; Frey S; DiGianvittorio M; Bleiler JK; Reyes DK; Abdallah R; Pienta KJ; Gorin MA; Pomper MG
    J Nucl Med; 2020 Feb; 61(2):183-188. PubMed ID: 31451492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMA-Targeted
    Gorin MA; Rowe SP; Hooper JE; Kates M; Hammers HJ; Szabo Z; Pomper MG; Allaf ME
    Eur Urol; 2017 Jan; 71(1):145-146. PubMed ID: 27363386
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between
    Liu Y; Dong Y; Liu J; Zhang X; Lin M; Xu B
    Prostate; 2021 Dec; 81(16):1329-1336. PubMed ID: 34516670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative Parameters in PSMA-Targeted PET Imaging with
    Li X; Rowe SP; Leal JP; Gorin MA; Allaf ME; Ross AE; Pienta KJ; Lodge MA; Pomper MG
    J Nucl Med; 2017 Jun; 58(6):942-946. PubMed ID: 27932557
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.
    Szabo Z; Mena E; Rowe SP; Plyku D; Nidal R; Eisenberger MA; Antonarakis ES; Fan H; Dannals RF; Chen Y; Mease RC; Vranesic M; Bhatnagar A; Sgouros G; Cho SY; Pomper MG
    Mol Imaging Biol; 2015 Aug; 17(4):565-74. PubMed ID: 25896814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.
    Cornelis FH; Durack JC; Morris MJ; Scher HI; Solomon SB
    Clin Nucl Med; 2017 Dec; 42(12):e516-e518. PubMed ID: 29099733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT.
    Rowe SP; Gorin MA; Chu LC; Pienta KJ; Pomper MG; Ross AE; Macura KJ
    Clin Nucl Med; 2017 Oct; 42(10):e441-e443. PubMed ID: 28806262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on
    Werner RA; Bundschuh RA; Bundschuh L; Javadi MS; Leal JP; Higuchi T; Pienta KJ; Buck AK; Pomper MG; Gorin MA; Lapa C; Rowe SP
    J Nucl Med; 2018 Dec; 59(12):1857-1864. PubMed ID: 30190304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [
    Werner RA; Bundschuh RA; Bundschuh L; Lapa C; Yin Y; Javadi MS; Buck AK; Higuchi T; Pienta KJ; Pomper MG; Lodge MA; Gorin MA; Rowe SP
    Mol Imaging Biol; 2020 Feb; 22(1):190-197. PubMed ID: 31140110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi.
    Gorin MA; Marashdeh W; Ross AE; Allaf ME; Pienta KJ; Pomper MG; Rowe SP
    Nucl Med Commun; 2017 Sep; 38(9):795-798. PubMed ID: 28704341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?
    Rowe SP; Mana-Ay M; Javadi MS; Szabo Z; Leal JP; Pomper MG; Pienta KJ; Ross AE; Gorin MA
    Clin Genitourin Cancer; 2016 Feb; 14(1):e115-8. PubMed ID: 26603549
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate Cancer Local Recurrence Detected With Both
    Gorin MA; Pienta KJ; Pomper MG; Rowe SP
    Urology; 2017 Sep; 107():e9-e10. PubMed ID: 28641974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents.
    Endepols H; Morgenroth A; Zlatopolskiy BD; Krapf P; Zischler J; Richarz R; Muñoz Vásquez S; Neumaier B; Mottaghy FM
    BMC Cancer; 2019 Jun; 19(1):633. PubMed ID: 31242896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
    Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [
    Sahakyan K; Li X; Lodge MA; Werner RA; Bundschuh RA; Bundschuh L; Kulkarni HR; Schuchardt C; Baum RP; Pienta KJ; Pomper MG; Ross AE; Gorin MA; Rowe SP
    Mol Imaging Biol; 2020 Feb; 22(1):181-189. PubMed ID: 31115751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
    Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
    Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ortega C; Schaefferkoetter J; Veit-Haibach P; Anconina R; Berlin A; Perlis N; Metser U
    J Nucl Med; 2020 Nov; 61(11):1615-1620. PubMed ID: 32198311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study.
    Harsini S; Saprunoff H; Alden T; Mohammadi B; Wilson D; Bénard F
    J Nucl Med; 2021 Jan; 62(1):81-87. PubMed ID: 32385167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.